Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 0 | 0 | 0 | 3,798,510 | 3,775,672 |
| Cost of Goods | N/A | N/A | N/A | 1,664,033 | 1,665,695 |
| Gross Profit | N/A | N/A | N/A | 2,134,470 | 2,109,970 |
| Operating Expenses | 47,616 | 23,554 | 19,542 | 1,469,271 | 1,462,912 |
| Operating Income | -47,616 | -23,554 | -19,542 | 665,239 | 647,760 |
| Interest Expense | 0 | 832 | 444 | 123,915 | 162,073 |
| Other Income | -357 | 36 | -28 | -9,499 | -6,985 |
| Pre-tax Income | -47,973 | -24,350 | -20,014 | 531,825 | 478,702 |
| Income Tax | N/A | N/A | N/A | 101,376 | 100,868 |
| Net Income Continuous | -47,973 | -24,350 | -20,014 | 430,849 | 378,484 |
| Net Income | $-47,973 | $-24,350 | $-20,014 | $430,855 | $378,492 |
| EPS Basic Total Ops | -42.44 | -415.83 | -397.62 | N/A | N/A |
| EPS Basic Continuous Ops | -42.42 | -408.92 | -367.38 | N/A | N/A |
| EPS Diluted Total Ops | -42.44 | -415.83 | -397.62 | N/A | N/A |
| EPS Diluted Continuous Ops | -42.42 | -408.92 | -367.38 | N/A | N/A |
| EBITDA(a) | $-44,250 | $-22,256 | $-18,617 | $1,107,339 | $1,140,950 |